We next investigated the effects produced by perturbation of O-GlcNAc levels on the expression of stem cell markers CD44 and CD133 by pharmacological inhibition of OGT or OGA in colon cancer cells. The gene discussed is CD44; the disease is malignant colon neoplasm.